Telerehabilitation for TMD

NCT ID: NCT05318313

Last Updated: 2026-01-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

207 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-17

Study Completion Date

2024-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will compare after physical therapy for Temporomandibular Disorders (TMD) performed either in-person or virtually using telerehabilitation. Comparing diagnostic reliability and quality-of-life outcomes in each group will determine (based on a 10% margin) whether delivering physical therapy via telerehabilitation is as good as standard in-person care for these individuals. Long term outcomes including patient satisfaction, cost-effectiveness analysis, and functional status will describe the feasibility of telerehabilitation as a management intervention for this population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Temporomandibular Disorder TMJ Disc Displacement With Reduction TMJ Disc Displacement Without Reduction Masticatory Myofascial Pain TMJ Arthralgia TMD Headache

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Telerehabilitation only

Participants choose to have all of their physical therapy provided virtually throughout the length of the study

Telerehabilitation

Intervention Type OTHER

The TR PT evaluation and follow-up visits will be performed via Zoom software

In-person only

Participants choose to have all of their physical therapy provided in-person throughout the length of the study

No interventions assigned to this group

Hybrid 1

The TR PT evaluation and follow-up visits in the initial 6 weeks will be performed via Zoom software and subsequent follow-up visits will switch to in person after 6 weeks

Telerehabilitation

Intervention Type OTHER

The TR PT evaluation and follow-up visits will be performed via Zoom software

Hybrid 2

The PT evaluation and follow-up visits in the initial 6 weeks will be performed in person and will switch to TR via Zoom software after 6 weeks

Telerehabilitation

Intervention Type OTHER

The TR PT evaluation and follow-up visits will be performed via Zoom software

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telerehabilitation

The TR PT evaluation and follow-up visits will be performed via Zoom software

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-70 years old
* Referred to PT with ≥1 TMD subtype diagnosis
* PI has no previous knowledge of the participant's diagnosis
* Email access
* Possession of any device that can be positioned for hands-free TR visits (TR group only)
* Willingness and ability to comply with all study requirements and PT program
* Able to provide informed consent

Exclusion Criteria

* Non-English speakers
* Permanent residence outside of the state of Minnesota (TR group only)
* Women in the last trimester of pregnancy
* Referred for post-surgical rehabilitation
* Severe chronic pain as identified by level 4 classification on the GCPS
* Current diagnosis or existence of the following conditions that can limit response to PT and participation in study activities:

1. Neuropathic pain
2. Fibromyalgia and/or generalized widespread pain on both sides of the body in ≥3 areas above and below the waist
3. Rheumatoid arthritis or juvenile idiopathic arthritis
4. Dystonia or other movement disorder
5. Fractures and/or recent jaw or facial trauma
6. Malignancies
7. Current substance abuse
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Minnesota

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emily Kahnert

Role: PRINCIPAL_INVESTIGATOR

University of Minnesota

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Minnesota

Minneapolis, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DENT-2022-30141

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.